Argos Therapeutics

BiotechnologySeries EDurham, USargostherapeutics.com

Latest round

Series E

Last raised

Aug 2013

Total raised

$137M

Investors

24

About Argos Therapeutics

Founded in 1997, Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases.

Who invested in Argos Therapeutics

24 investors across 7 rounds

See all investors in Argos Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series E

    Aug 26, 2013

    Amount

    $43M

    Investors

    Locked

  2. Series D

    Sep 11, 2012

    Amount

    $14M

    Investors

    Locked

  3. Series D

    Apr 9, 2012

    Amount

    $9M

    Investors

    Locked

  4. Series C

    Apr 23, 2008

    Amount

    $17M

    Investors

    Locked

  5. Series C

    Mar 28, 2008

    Amount

    $13M

    Investors

    Locked

  6. Series B

    Sep 10, 2001

    Amount

    $40M

    Investors

    Locked

  7. Series A

    Jun 1, 2000

    Amount

    $1.6M

    Investors

    Locked

Questions about Argos Therapeutics

Who invested in Argos Therapeutics?

Argos Therapeutics has 24 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Argos Therapeutics raised?

Argos Therapeutics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.

When did Argos Therapeutics last raise money?

Argos Therapeutics's most recent round on record is a Series E, in Aug 2013.

What does Argos Therapeutics do?

Founded in 1997, Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases.

Where is Argos Therapeutics headquartered?

Argos Therapeutics is headquartered in Durham, US.

Which VCs invest in companies like Argos Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Argos Therapeutics's stage. Their profiles are linked below.

Raising like Argos Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.